Merger documents

Explore the information relating to the merger

Press releases

Final results of the exchange offer: 96.1% of DSM ordinary shares tendered

01.05.2023

dsm-firmenich first day of trading on Euronext Amsterdam

18.04.2023

Exchange offer declared unconditional

17.04.2023

Second supplement to offering circular

06.04.2023

DSM and Firmenich have obtained all competition clearances

04.04.2023

Acceptance period second extension announcement

31.03.2023

DSM and Firmenich have obtained competition clearance from the European Commission

23.02.2023

Acceptance period extension announcement

23.01.2023

DSM announces results of EGM

23.01.2023

Exchange offer & EGM announcement

22.11.2022

dsm-firmenich update on public exchange offer process

28.06.2022

DSM and Firmenich confirm leadership team

13.06.2022

Merger announcement (EN)

31.05.2022

Merger announcement (FR)

31.05.2022

Merger announcement (DE)

31.05.2022

Merger announcement (NL)

31.05.2022

Presentations

EGM presentation – 23 Jan

23.01.2023

Watch the recording

Investor presentation - 22 Nov

22.11.2022

Watch the recording

Investor presentation - 13 June (EN)

13.06.2022

Capital markets day presentation - 13 June (EN)

13.06.2022

Watch the recording

Investor call transcript - 31 May (EN)

08.06.2022

Investor presentation - 31 May (EN)

31.05.2022

Listen to the investor call recording

Media presentation (EN)

31.05.2022

Listen to the media call recording

Documents related to the offering circular

Second supplement to the offering circular

06.04.2023

Supplement to the offering circular

03.03.2023

Offering circular

22.11.2022

U.S. investor letter

Financial information referenced in the offering circular

Firmenich Q1 2023 trading update

22.11.2022

Firmenich annual report for the financial year ended 2022

Firmenich interim consolidated financial statements for the six months ended 31 December 2021

Firmenich annual report for the financial year ended 2021

Firmenich interim consolidated financial statements for the six months ended 31 December 2020

Firmenich annual report for the financial year ended 2020

DSM Q3 2022 trading update

22.11.2022

DSM HY 2022 financial statements & auditor's report

22.11.2022

DSM consolidated financial statements for the financial years ended 31 December 2021 and 2020 & auditor’s report

22.11.2022

DSM integrated annual report 2021

DSM integrated annual report 2020

DSM integrated annual report 2019

Documents related to the DSM EGM

EGM voting results

23.01.2023

EGM minutes

23.01.2023

Position statement

Convocation notice, agenda & notes

22.11.2022

Form B - proxy

Form A - notification

22.11.2022

DSM virtual meeting manual & FAQ

22.11.2022

Form C - voting instructions

Proposed amendment to the Articles of Association for the conversion of DSM N.V. into DSM B.V.

DSM's policy regarding hybrid shareholder meetings

Merger proposal

Merger proposal: Schedule A

Merger proposal: Schedule B

Merger proposal: Schedule C

Merger proposal: Schedule D (Auditor's report)

22.11.2022

Merger Proposal: Explanatory notes

22.11.2022

Explanatory Notes: Schedule (Auditor’s assurance report)

Explore more

Results center

All the key financial performance information published by DSM and Firmenich prior to our merger, plus financial information published by dsm-firmenich.

Read more
Investors

Two global leaders in science and innovation have joined forces to become dsm-firmenich, creating a world of potential for investors.

Read more
Share performance

Tools to track your share performance.

Read more